FDA Drug Recalls

Recalls / Class III

Class IIID-0094-2024

Product

Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla Life Sciences US Inc., Wayne, PA 19087. NDC: 69344-213-11

Brand name
Oxaydo
Generic name
Oxycodone Hydrochloride
Active ingredient
Oxycodone Hydrochloride
Route
Oral
NDCs
69344-113, 69344-213
FDA application
NDA202080
Affected lot / code info
Lot 22W02, Exp 01/31/2025

Why it was recalled

Sub-potent Drug: Lower potency than labeled.

Recalling firm

Firm
Zyla Life Sciences US Inc.
Manufacturer
Zyla Life Sciences US LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
100 Saunders Rd, Ste 300, Lake Forest, Illinois 60045-2502

Distribution

Quantity
3,792 bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2023-10-20
FDA classified
2023-11-08
Posted by FDA
2023-11-15
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0094-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.